Methods used to assess patient's coagulation status
| Method of assessment | Number (%) n=102 | Neurosurgical unit number (%) n=25 | Non-neurosurgical unit number (%) n=77 |
|---|---|---|---|
| INR/near-patient INR | 67 (65.7%) | 12 (48%) | 55 (71%) |
| Coagulation/clotting screen | 48 (47.1%) | 9 (36%) | 39 (51%) |
| Liver function tests | 3 (2.9%) | 1 (4%) | 2 (3%) |
| Laboratory tests (not specified) | 8 (7.8%) | 2 (8%) | 6 (8%) |
| ROTEM or TEG | 11 (10.8%) | 7 (28%) | 4 (5%) |
| Full blood count | 15 (14.7%) | 3 (12%) | 12 (16%) |
| Clinical findings | 8 (7.8%) | 2 (8%) | 6 (8%) |
| Platelets | 6 (5.9%) | 2(8%) | 4 (5%) |
| Fibrinogen/fibrin degradation product | 16 (15.7%) | 3(12%) | 13 (17%) |
| Activated partial thromboplastin time | 16 (15.7%) | 2 (8%) | 14 (18%) |
| Prothrombin time | 6 (5.9%) | 2 (8%) | 4 (5%) |
| Other | 6 (5.9%) | 4 (16%) | 2 (3%) |
| Liaise with haematology | 2 (2.0%) | 0 (0%) | 2 (3%) |
Other: haemoglobin, thrombin time, intracellular calcium, arterial and venous blood gases, D Dimer and Urea and Electrolytes (U&Es).
Free text box is used and so any number of responses is permitted. Total respondents=102.
INR, International normalised ratio; ROTEM, rotational thromboelastometry; TEG, thromboelastography.